|
T12345 |
CBP/p300-IN-3
|
P300/CBP-IN-3 |
Histone Acetyltransferase
|
|
CBP/p300-IN-3 (P300/CBP-IN-3) is an inhibitor of p300/CBP histone acetyltransferase. |
|
T7264 |
CBP/EP300-IN-1
|
|
Epigenetic Reader Domain
|
|
CBP/EP300-IN-1 is a CBP/EP300 bromodomain inhibitor. |
|
T10717 |
Inobrodib
|
CBP-IN-1 |
Epigenetic Reader Domain
|
|
Inobrodib (CBP-IN-1) is a potent inhibitor of p300/CBP bromodomain. |
|
T24197 |
XDM-CBP
|
XDMCBP,XDM CBP |
|
|
XDM-CBP is an effective and selective CBP/p300 bromodomain inhibitor. |
|
T39826 |
CBP/p300-IN-8
|
CBP/p300-IN-8 |
|
|
CBP/p300-IN-8 is a potent inhibitor of the CBP/P300 family of bromodomains . CBP/p300-IN-8 inhibits CBP ( IC 50 =0.01-0.1 μΜ) and BRD4 ( IC 50 =1-1000 μΜ) activity. |
|
T40344 |
CBP/p300-IN-14
|
CBP/p300-IN-14 |
|
|
CBP/p300-IN-14, efficiently inhibits CBP/EP300 (lysine acetyltransferase) with an IC50 value of 3.3 nM. |
|
T40143 |
PROTAC CBP/P300 Degrader-1
|
PROTAC CBP/P300 Degrader-1 |
|
|
PROTAC CBP/P300 Degrader-1 is an effective compound that degrades CBP/P300 in a potent manner. It significantly reduces cell viability in various cancer cell lines. |
|
T10702 |
CBP/p300-IN-2
|
CBP/EP300-IN-2 |
Epigenetic Reader Domain
,
c-Myc
|
|
CBP/EP300-IN-2 is an inhibitor of CBP/EP300 (IC50s: 1.07 nM and 5.96 nM for CBP/HTRF and Myc). |
|
T12346 |
CBP/p300-IN-5
|
P300/CBP-IN-5 |
Epigenetic Reader Domain
|
|
P300/CBP-IN-5 is a potent inhibitor of p300/CBP histone acetyltransferase (IC50 of 18.8 nM). |
|
T68895 |
CBP-93872
|
|
|
|
CBP-93872 is a G2 checkpoint inhibitor. CBP-93872 specifically abrogates the DNA double-stranded break (DSB)-induced G2 checkpoint through inhibiting maintenance. CBP-93872 is an inhibitor of maintenance of the DSB-speci... |
|
T40142 |
Thalidomide-NH-CBP/p300 ligand 2
|
Thalidomide-NH-CBP/p300 ligand 2 |
|
|
Thalidomide-NH-CBP/p300 ligand 2 (P-007) is a PROTAC-based compound designed to degrade CBP and p300, acting as a functional antagonist (WO2020173440). |
|
T26962 |
CBP-307
|
CBP307 |
|
|
CBP-307 is a selective second generation S1P1 (a G-protein coupled receptor -GPCR) modulator. |
|
T40144 |
CBP/p300 ligand 2
|
|
|
|
CBP/p300 ligand 2 is a selective ligand that binds to the target protein for PROTAC of dCBP-1, a potent and selective heterobifunctional degrader of p300/CBP. |
|
T12537 |
β-catenin/CBP-IN-1
|
|
Wnt/beta-catenin
|
|
β-catenin/CBP-IN-1 is a potent and selective inhibitor of CBP/β-catenin |
|
T62415 |
CBP/p300-IN-17
|
|
|
|
CBP/p300-IN-17 (compound 7) is a potent inhibitor of EP300/CBP HAT, acting on HAT EP300 (IC50: 0.18 μM) and LK2 H3K27 (IC50: 0.69 μM). |
|
T79168 |
CBP-IN-1
|
|
Epigenetic Reader Domain
|
|
CBP-IN-1 (compound 12) acts as a potent CBP inhibitor exhibiting an IC50 of 1.5 nM and additionally suppresses CBP BRET and BRD4(1) with IC50 values of 690 nM and 3100 nM, respectively [1]. |
|
T63122 |
CBP/p300-IN-19
|
|
|
|
CBP/p300-IN-19 is a potent inhibitor of p300/CBP HAT, which can act on P300-HAT (IC50: 1.4 μM), CBP-HAT (IC50: 1.4 μm), 2.2 μM), PCAF (IC50>100 μM), and Myst3 (IC50>100 μM). CBP/p300-IN-19 has anti-tumor activity. |
|
T63110 |
CBP/p300-IN-15
|
|
|
|
CBP/p300-IN-15 (compound 13a) is a potent inhibitor of p300 (IC50: 2.5 nM) and CBP (IC50: 28.0 nM). p300-IN-15 inhibits OVCAR-3 cells (EC50: 0.865 μM) and A2780 cells (EC50. 2.71 μM). 2.71 μM). CBP/p300-IN-15 can be used... |
|
T62720 |
CBP/p300-IN-18
|
|
|
|
CBP/p300-IN-18 (compound 8) is a potent inhibitor of EP300/CBP HAT, acting on HAT EP300 (IC50: 0.056 μM) and LK2 H3K27 (IC50: 0.46 μM). |
|
T3969 |
I-CBP112
|
|
Epigenetic Reader Domain
,
Histone Acetyltransferase
|
|
I-CBP112 is a specific and potent acetyl-lysine competitive protein-protein interaction inhibitor targeting the CBP/p300 bromodomains. |
|
T81314 |
Rademikibart
|
CBP-201 |
|
|
Rademikibart (CBP-201) is a human monoclonal antibody selective for IL-4Rα, exhibiting strong affinity with a KD of 20.7 pM for human IL-4Rα epitopes, without cross-reactivity to IL-4Rα from other species. It effectively... |
|
T79395 |
CBP/p300-IN-21
|
|
Epigenetic Reader Domain
|
|
CBP/p300-IN-21 (Compound 5d), a selective inhibitor of CBP/p300 with IC50 values of 0.07 μM for p300 and 1.755 μM for CBP, reduces H3K18Ac levels and inhibits the growth of 4T1 tumors in mice [1]. |
|
T62700 |
CBP/p300-IN-16
|
|
|
|
CBP/p300-IN-16 (compound 1) is a potent inhibitor of EP300/CBP HAT, acting on HAT EP300 (IC50: 0.61 μM) and LK2 H3K27 (IC50: 2.24 μM). |
|
T72815 |
CBP/p300-IN-10
|
|
|
|
CBP/p300-IN-10, a potent inhibitor targeting histone acetyltransferase enzymes EP300 and CREBBP, exhibits IC50 values of 26 nM and 39 nM, respectively. This compound shows potential for anticancer research applications. |
|
T4247 |
I-CBP112 hydrochloride
|
|
Epigenetic Reader Domain
|
|
I-CBP112 is a selective inhibitor of the bromodomain-containing transcription factors. I-CBP112 (1 mM) has little activity against other bromodomains. I-CBP112 targets the CBP/p300 bromodomains. I-CBP112 significantly re... |
|
T63565 |
CBP/p300-IN-19 hydrochloride
|
|
|
|
CBP/p300-IN-19 hydrochloride is a selective and potent inhibitor of p300/CBP HAT, capable of acting on p300-HAT (IC50: 1.4 μM), CBP-HAT (IC50: 2.2 μM), PCAF (IC50>100 μM), Myst3 (IC50>100 μM). CBP/p300-IN-19 hydrochlorid... |
|
T28004 |
MDK8228
|
PF-CBP/BRD4,MDK-8228,MDK 8228 |
|
|
MDK8228 is an inhibitor of CBP/p300 and BRD4 bromodomain. MDK8228 downregulates IL-6, IL-ß and IFN-ß in macrophages. |
|
T3973 |
PF-CBP1
|
|
Epigenetic Reader Domain
|
|
PF-CBP1 HCl is a highly selective inhibitor of the bromodomain of CREB-binding protein(CREBBP). It inhibits CREBBP (IC50: 125 nM) and p300 bromodomains (IC50: 363 nM). |
|
T9370 |
DCBP-1
|
|
Epigenetic Reader Domain
,
Ligand for E3 Ligase
|
|
dCBP-1 is a chemical degrader of p300/CBP. dCBP-1 hijacks the E3 ubiquitin ligase CRBN for selective degradation of p300/CBP. Degradation of p300/CBP by dCBP-1 leads to effective multiple myeloma cell killing. |
|
T8778 |
TTK21
|
|
Epigenetic Reader Domain
|
|
TTK21 is an activator of CBP/p300 histone acetyltransferase activity. |
|
T6668 |
SGC-CBP30
|
|
Epigenetic Reader Domain
,
Histone Acetyltransferase
|
|
SGC-CBP30 is an effective CREBBP/EP300 inhibitor (IC50: 21/38 nM). |
|
T7856 |
Naphthol AS-E
|
nAS-E |
Epigenetic Reader Domain
,
Histone Acetyltransferase
|
|
Naphthol AS-E (nAS-E) is an the KIX-KID interaction and CREB-mediated gene transcription inhibitor. |
|
T3635 |
IQ 1
|
IQ1,IQ-1 |
Wnt/beta-catenin
|
|
IQ 1 has multiple roles, such as maintaining the multifunctionality of mouse ESCs, decreasing Wnt-stimulated phosphorylation, blocking PP2A/Nkd interactions, and so on. |
|
T8658 |
NEO2734
|
EP31670 |
Epigenetic Reader Domain
,
Histone Acetyltransferase
|
|
NEO2734 (EP31670) is an orally active and selective inhibitor of p300/CBP and BET bromodomain(IC50 of <30 nM for both p300/CBP and BET bromodomains). |
|
T3217 |
PF-CBP1 hydrochloride
|
PF-CBP1 HCl |
Epigenetic Reader Domain
,
Histone Acetyltransferase
|
|
PF-CBP1 hydrochloride (PF-CBP1 HCl) is a highly selective inhibitor of the bromodomain of CREB-binding protein(CREBBP).It inhibits CREBBP and p300 bromodomains with IC50 of 125 and 363 nM respectively. |
|
T9373 |
DCH36_06
|
(5E)-1-(3-chloro-4-methylphenyl)-5-[(2E)-3-(furan-2-yl)prop-2-en-1-ylidene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione |
Apoptosis
,
Epigenetic Reader Domain
,
Histone Acetyltransferase
|
|
DCH36_06 ((5E)-1-(3-chloro-4-methylphenyl)-5-[(2E)-3-(furan-2-yl)prop-2-en-1-ylidene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione) as a bona fide is a potent p300/CBP inhibitor |
|
T78455 |
Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2
|
|
|
|
Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 is a potent ruthenium-based dye that serves as an effective quencher for quantum dots (QDs) fluorescence and as a capture probe for the virus antigen EV71. Additionally, it can be utilize... |
|
T69091 |
CBP501
|
|
|
|
CBP501 is a peptide with G2 checkpoint-abrogating activity. G2 checkpoint inhibitor CBP501 inhibits multiple serine/threonine kinases, including MAPKAP-K2, C-Tak1, and CHK1, that phosphorylate serine 216 of the dual-spec... |
|
T80132 |
CBP501 Affinity Peptide
|
|
|
|
CBP501 Affinity Peptide, a Chk kinase inhibitor, disrupts G2 arrest triggered by DNA-damaging agents and is utilized in cancer research [1]. |
|
T81250 |
Ru(bpy)2(dcbpy)NHS dihexafluorophosphate
|
|
|
|
Ru(bpy)2(dcbpy)NHS dihexafluorophosphate, when coupled with gold nanoparticle amplification, serves as a method for lysozyme detection via electrochemiluminescence [1]. |
|
T14073 |
A-485
|
|
Epigenetic Reader Domain
,
Histone Acetyltransferase
|
|
A-485 is a potent and selective catalytic p300/CBP inhibitor(IC50s of 9.8 nM and 2.6 nM for p300 and CBP, respectively). |
|
T6811 |
CPI-637
|
CPI 637 |
Epigenetic Reader Domain
,
Histone Acetyltransferase
|
|
CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibitor. |
|
T2237 |
ICG001
|
|
Epigenetic Reader Domain
,
Wnt/beta-catenin
|
|
ICG001 (PRI-724 isomer) antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CREB)-binding protein (CBP) with IC50 of 3 μM, but is not the related transcriptional coacti... |
|
T15216 |
EML 425
|
|
Epigenetic Reader Domain
,
Histone Acetyltransferase
|
|
EML 425 is a potent and selective inhibitor of CREB binding protein (CBP)/p300 (IC50s: 2.9 and 1.1 μM, respectively). |
|
T6113 |
ICG-001
|
|
Apoptosis
,
Epigenetic Reader Domain
,
Wnt/beta-catenin
|
|
ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CBP) with IC50 of 3 μM, but is not the related transcriptional coactivator p300. |
|
T5468 |
YF-2
|
|
Others
,
Epigenetic Reader Domain
,
Histone Acetyltransferase
|
|
YF-2 is blood-brain-barrier permeable histone acetyltransferase activator, acetylates H3 in the hippocampus, CBP, PCAF, and GCN5 with EC50s of 2.75 μM, 29.04 μM and 49.31 μM , respectively |
|
T16154 |
MS417
|
GTPL7512 |
Epigenetic Reader Domain
,
HIV Protease
|
|
MS417 (GTPL7512) is an inhibitor of BET-specific BRD4(BRD4-BD1 and BRD4-BD2 with IC50s of 30, 46 nM and Kds of 36.1, 25.4 nM, respectively), with weak selectivity at CBP BRD with IC50 of 32.7 μM. |
|
T15405 |
GNE-781
|
|
Epigenetic Reader Domain
|
|
GNE-781 is a highly potent and selective inhibitor of CBP (IC50: 0.94 nM in TR-FRET assay). GNE-781 also inhibits BRET and BRD4(1) (IC50s: 6.2 nM and 5100 nM, respectively). |
|
T10641 |
C-82
|
|
Epigenetic Reader Domain
,
Wnt/beta-catenin
|
|
C-82 is a specific CBP/β-catenin antagonist. It inhibits the binding between β-catenin and CBP and increases the binding between β-catenin and p300. |
|
T50014 |
2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one
|
|
Epigenetic Reader Domain
|
|
2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP. |
